Recently Featured

New Survey Reveals Mental Health Outcomes Linked to Gender Euphoria

April 1, 2026
A recent survey has highlighted significant mental health outcomes associated with gender euphoria, a phenomenon increasingly recognized within the scientific community. This survey provides crucial data that underscores the psychological benefits experienced by individuals who affirm their gender identity, suggesting a positive correlation between gender euphoria and overall mental well-being. The context of this survey…

BASF Pharma Solutions Implements Up to 20% Price Increase Amid Rising Costs

April 1, 2026
BASF Pharma Solutions has announced a price increase of up to 20% for its excipients and select active pharmaceutical ingredients (APIs), effective immediately. This decision comes in response to escalating energy and raw material costs that have been impacting the pharmaceutical supply chain. The rising costs of energy and raw materials have been a persistent…

Psychedelic Biotechs Under Scrutiny for YouTube Promotions

April 1, 2026
Psychedelic biotech companies are facing increased scrutiny over their promotional activities on YouTube, raising concerns among regulators and industry stakeholders. Recent reports indicate that these firms have been utilizing social media platforms to market their products, which may not align with existing advertising regulations for pharmaceuticals. This trend highlights a growing tension between innovative marketing…

Manufacturers in Northern Ireland Must Navigate EU Medical Device Regulations for Clinical Investigations

March 31, 2026
Manufacturers in Northern Ireland are required to adhere to stringent EU medical device regulations when conducting clinical investigations. This regulatory framework is crucial for ensuring that medical devices meet safety and efficacy standards before they reach the market. Compliance not only safeguards public health but also enhances the credibility of manufacturers in a competitive landscape.…

Ongoing Cases